Oxidative stress is considered as a major causative factor in the progression of chronic liver diseases. A recent observation of hepatic iron overload in patients with alcoholic liver disease, chronic hepatitis C and nonalcoholic steatohepatitis (NASH), suggests that iron-induced oxidative stress plays an important role in the pathogenesis of chronic liver diseases.1) We have previously reported that a transgenic mouse, which develops steatohepatitis by liver-specific impairment of retinoid signaling, shows significant hepatic iron overload.2,3) It is also known that abnormal lipid metabolism and iron metabolism frequently coexist in chronic liver diseases, although it remains unclear whether the iron metabolism is related to the lipid metabolism in the liver. Choline is an essential nutrient with roles in cell membrane integrity, transmembrane signaling, phosphatidylcholine synthesis and methyl metabolism. The role of dietary choline deficiency in promoting hepatic steatosis and reduced plasma VLDL levels is well established, and the mice fed a choline-deficient diet (CD mice) has been used as a model for non-alcoholic fatty liver disease (NAFLD).
4)Accumulating evidence suggests that dysregulation of hepcidin (HEPC) expression is one of the primary causes of hepatic iron overload. 5) Hemojuvelin (HJV), transferrin receptor 2 (TfR2) and hepatocellular iron content have been reported to be positive regulators of HEPC expression while transmembrane serine protease 6 (TMPRSS6) is its negative regulator. [6][7][8] It is thought that HEPC decreases total body iron amount by inhibiting iron absorption through cellular iron exporter ferroportin (FPN) expressed on the basolateral membrane of small intestinal epithelial cells. 9) Our previous results suggested that FPN, which is present in the liver, plays a role in hepatic iron efflux.2) In addition, the genes, whose expression is regulated through iron responsive element (IRE), such as transferrin receptor 1 (Tfr1), ferritin light chain (Ftl) and divalent metal ion transporter 1 (Dmt1), 10) are expected to be altered in accordance with hepatic iron accumulation. Since FPN is also an IRE-regulated gene, 10) its regulation seems to be complicated. In the present study, we try to clarify the possible link between iron and lipid metabolism in steatotic livers of CD mice.
MATERIALS AND METHODS
Animal TreatmentSix weeks old male C57BL/6J mice (CLEA Japan, Tokyo, Japan) were fed with normal diet (CE-2, CLEA Japan; nϭ6) or CD diet (Dyets Inc., Bethlehem, PA, U.S.A.; nϭ9) for 12 weeks. The mice were kept under pathogen-free conditions, and were maintained in a temperature-controlled room with a 12 h light/dark illumination cycle. Animals received humane care in accordance with study guidelines established by the Tottori University Subcommittee on Laboratory Animal Care.Biochemical Analysis Determination of hepatic nonheme iron using bathophenantrolinedisulfonate was performed according to the previous report.2) Hepatic non-escerified fatty acid (NEFA) and triglyceride (TG) con...